ESR2 and Chronic colitis: Moreover, treatment with ERβ agonist ERB041 could significantly restore the frequency of TIGIT+ Tregs and alleviate DSS-induced chronic colitis and inflammation in mouse models, implicating the potential roles of TIGIT expressed on Tregs during the development of chronic colitis (92).